Evidence vs. Food and Drug Administration
Based on the registry return receipt for my letter, designated as 6_29_10_4, said letter addressed to the Bureau of Food and Drug, was received on 05_07_2010 by the
Food and Drug Administration. Despite R.A. 6713, which said bureau is required to obey, up to September 17, 2010,
said bureau has not provided me with acknowledgment that it received said letter and has not informed me what it did with said letter.



http://www.bfad.gov.ph/cfc/pdf.cfm?pdfid=1473
FDA Circular No. 2010-015
Declaring the Identified Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or
Distribution

FDA approves pediatric use of chemical poisoning treatment
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225347.htm



facts random history web site
http://facts.randomhistory.com/


Nationwide Philhealth Registration Day

Philhealth Sabado - October 2PhilHealth Sabado (October 2, 2010) is the start of a continuing advocacy program to increase awareness and knowledge of every Filipino on the importance of becoming a PhilHealth member that will ensure access to quality health services to the member and his/her dependents.
http://www.doh.gov.ph/node/2804.html
The program intends the registration of non-member informal sector under the individually paying program (IPP). It also provides for an opportunity to automatically register and distribute PhilHealth cards to about 800,000 indigents identified in the National Household Targeting System (NHTS) of the Department of Social Welfare and Development (DSWD).

PhilHealth Sabado fullfill universal health insurance coverage within three years as promised in the first State of the Nation Address of President Benigno S. Aquino III.

1. Paraan ng Pagpaparehistro
2. Paraan ng Paggamit
- Sponsored Program Members
- Individually Paying Members
3. Alamin ang Inyong Benepisyo
4. Frequently Asked Questions

PRESENTATIONS

1. National Philhealth Registration Day
2. National Philhealth Registration Day - Communication Plan
3. Dry-Run of the National Philhealth Registration Day
4. NPRD Joint Agreement


FDA issues new dosing guidance for children using Valcyte
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225887.htm
For Immediate Release: Sept. 15, 2010
Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA





Updated drug label will help prevent potential overdose in underweight transplant patients

The U.S. Food and Drug Administration is notifying health care professionals of updated dosing recommendations for Valcyte (valganciclovir) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant. The update is intended to prevent drug overdosing of children with low body weight, low body surface area, and very low serum creatinine. The revised dosing instructions now appear in the product’s label.

The revised pediatric dosing recommendations now include an upper limit on “calculated creatinine clearance,” a measurement of kidney function. Creatinine is a waste product produced by the body during energy production and is eliminated by the kidneys.
Creatinine levels in the blood are used to estimate how well kidneys are functioning. High creatinine levels may signal poor kidney function, while low creatinine levels may be observed in patients who are not muscular.

Valcyte is an antiviral medication that can be effective for the prevention of cytomegalovirus (CMV) disease in children from 4 months to 16 years of age who have undergone a kidney or heart transplant and who are at a higher risk of getting the disease. CMV is a virus that can cause severe disease such as pneumonia or colitis in people with weakened immune systems, including organ transplant patients.

People using the medication should speak with their health care professional if they have questions about their Valcyte dose.

The medication is also approved to treat CMV retinitis (when the virus infects the eyes) in adults who have acquired immunodeficiency syndrome (AIDS) and is used to prevent CMV disease in people who have received a heart, kidney, or kidney-pancreas transplant with a high risk of getting CMV disease.



Valcyte is manufactured by San Francisco-based Genentech, a member of the Roche Group.

For more information:

Valcyte Drug Safety Communication
http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm


#



RSS Feed for FDA News Releases [what is RSS?]

-
-
Links on this page:

1. http://www.fda.gov/MedWatch/report.htm
2. http://www.fda.gov/MedWatch/getforms.htm
3. http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm
4. http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml
5. http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/ucm144575.htm

Page Last Updated: 09/15/2010


http://ocw.mit.edu/index.htm
free online course materials Massachusetts Institute of Technology


The Cost of Flooding
http://www.floodsmart.gov/floodsmart/pages/flooding_flood_risks/the_cost_of_flooding.jsp
All it takes is a few inches of water to cause major damage to your home and its contents. This interactive tool shows you what a flood to your home could cost,
inch by inch.




Manila Health Department refused to accept letter?
I sent a letter to the Manila Health Department. Said letter was designated as registered letter No. 1889. Said letter was mailed on April 25, 2010.
I received back said letter.Based on the marking on the said envelope, said department refused to accept said letter.


Food and Drug Administration Philippines News and Announcements
News and Announcements
DOH_FDA_ADVISORY_2010-010: Product Recall Order For Alactagrow Bibo Trio Milk Supplement Covered by Registration No. FR-71538
DOH_FDA_ADVISORY_2010-009: Product Recall Order of Sustagen Junior Milk Drink Powder Vanilla Flavor (For 1-3 Years Old) Covered by Registration Number FR-72110

FDAC 2010-015: Declaring the Identified Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution

PNS/FDA 27:2010: Recommended Code of Practice for the Processing and Handling of Smoked Fish
PNS/FDA 26:2010: Smoked Fish - Specification
PNS/FDA 25:2010: Recommended Code of Practice for the Processing and Handling of Purple Yam (Ube) Jam (Halaya)
PNS/FDA 24:2010: Purple Yam (Ube) Jam (Halaya) - Specification
PNS/BFAD 29:2010: Recommended Code of Practice for the Processing and Handling of Processed Pili Nut Products
PNS/BFAD 28:2010: Processed Pili Nut Products - Specification
PNS/BFAD 23:2010: Recommended Code of Practice for the Processing and Handling of Fried Corn Snacks (Chichacorn)
PNS/BFAD 22:2010: Fried Corn Snacks (Chichacorn) - Specification
ASEAN Current Good Manufacturing Practice (cGMP) on Cosmetics
Paunawa mula sa DOH-FDA Blg. 2010-007: Babala sa Publiko Tungkol sa mga Produktong Herbal na Walang Label
FDAC 2010-011: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
Transplant Experts Commend DOH Issuance of AO on Deceased Donors Program
DOH Issues Administrative Order on Deceased Organ Donors
Statement of the Food and Drug Administration
DOH Mahalagang Paalala: Ang Food/Dietary Supplements ay HINDI GAMOT...........
FDA Circular No. 2010-009: Amendment to Memorandum Circular No. 05 series of 1994 regarding Reports on Adversed Drug Reaction
FDA Circular No. 2010-008: Adoption of the CODEX Standards of Food Contaminants in Processed Foods
DOH-FDA Advisory 2010-006: Reported Recall of Certain Infant and Children and Over-the-Counter Products Manufactured in the United States
FDA Advisory No. 2010-005: Rotarix Vaccine
FDA Advisory No. 2010-004: FDA Findings on Wheat Flour Imported from Turkey
AO 2010-0008: Directive Specific to the Change in the Use of the Phrase "No Approved Therapeutic Claim" in all Advertisement, Promotional, and/or Sponsorship Activities or Materials concerning Food/Dietary Supplements.
FDA Circular No. 2010-004: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
FDA Advisory 2010-003: Zhen De Shou Fat Loss Capsule and Zhen De Shou Fat Loss Tea
FDA Advisory 2010-002: Jiaoli Miraculuous Cream (Jiaoli); Jiaoli Huichusu Special Cut Genuine (Jiaoli Huichusu); and Jiaoli 2+1 7 days Clearing Facial Spots Suit (Jiaoli) Cosmetic Products
Paunawa Mula sa DOH - FDA Blg. 2010-001: Babala sa publiko tungkol sa Food Supplements
FDA CIRCULAR 2010-002: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
FDA CIRCULAR 2010-001: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
DOH-FDA Advisory 2009-010:Reported Proliferation of Expired Processed Food Products Including Dairy Products in the Market
BFAD CITIZEN'S CHARTER (RA 9485 - Anti-Red Tape)

CPSC Urges Parents to Inspect and Secure TVs, Furniture, and Appliances in Child-Proofing Efforts
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10351.html
On average, one child dies every two weeks due to tipovers

NEWS from CPSC
U.S. Consumer Product Safety Commission
Office of Information and Public Affairs Washington, DC 20207
FOR IMMEDIATE RELEASE
September 23, 2010
Release #10-351 CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908


CPSC Urges Parents to Inspect and Secure TVs, Furniture, and Appliances in Child-Proofing Efforts
On average, one child dies every two weeks due to tipovers

WASHINGTON, D.C. - Many parents and caregivers may not be aware that one of the top hidden hazards in the homes where young children live or visit is unsecured and
unstable TVs, furniture and appliances. Today, the U.S. Consumer Product Safety Commission (CPSC) is urging families to take a moment to inspect and secure these
items to prevent any more tragedies.

Between 2000 and 2008, CPSC staff received reports of nearly 200 tipover related deaths involving children eight years old and younger. Nearly all of these fatalities (93%) involved children five years old and younger.

More than 16,000 children five years old and younger were treated in emergency rooms because of injuries associated with TVs, furniture, and appliance tipovers according to CPSC staff’s most recent estimates from 2006.

“Large TVs and unstable furniture can be a deadly combination. Taking simple, low-cost steps to secure furniture and TVs can save lives,” said CPSC Chairman Inez
Tenenbaum. “Parents need to know about this hidden danger and take action now.”

Typically, injuries and deaths occur when children climb onto, fall against or pull themselves up on television stands, shelves, bookcases, dressers, desks, chests and appliances. In some cases, televisions placed on top of furniture will tip over and cause a child to suffer traumatic and sometimes fatal injuries.

To help prevent tip-over hazards, the CPSC offers the following safety tips:

* Furniture should be stable on its own. For added security, anchor chests, dressers, TV stands, bookcases and entertainment units to the floor or attach them to a wall.

* Place TVs on a sturdy, low-rise base. Avoid flimsy shelves.

* Push the TV as far back on its stand as possible.

* Place electrical cords out of a child’s reach and teach kids not to play with them.

* Keep remote controls and other attractive items off the TV stand so kids won’t be tempted to grab for them and risk knocking the TV over.

* Make sure free-standing ranges and stoves are installed with anti-tip brackets.

This year, the CPSC is intensifying its outreach efforts by partnering with numerous organizations, including clinics and second-hand stores, to disseminate a two minute PSA (transcript) including a powerful testimonial of a parent who lost her two-year-old in a TV tipover incident and a poster (pdf). In addition, consumers will be able to stream a 20 second version (transcript) of the PSA through October 23, 2010 by texting TVFALL to 878787.

Consumers can also download CPSC's updated safety alert (pdf).



DOH GEARS UP FOR LOCAL BREASTFEEDING CAMPAIGN
http://www.doh.gov.ph/
Health Secretary Enrique T. Ona reminds the public about the importance of breastfeeding within the first hour of life and called on health facilities providing healthcare for pregnant women, new mothers and newborns to follow the Ten Steps To Successful Breastfeeding.

During the ‘Breastfeeding Awareness Week’ held at the St. Luke’s Medical Center, Health Assistant Secretary Elmer Punzalan commended the participation of the SLMC as among the first private health facilities to respond to the DOH’s call to implement the Ten Steps To Successful Breastfeeding.

Health Secretary Enrique T. Ona reminds the public about the importance of breastfeeding within the first hour of life and called on health facilities providing healthcare for pregnant women, new mothers and newborns to follow the Ten Steps To Successful Breastfeeding.

During the ‘Breastfeeding Awareness Week’ held at the St. Luke’s Medical Center, Health Assistant Secretary Elmer Punzalan commended the participation of the SLMC as among the first private health facilities to respond to the DOH’s call to implement the Ten Steps To Successful Breastfeeding.

Globally, the Philippines is one of 33 countries that have completed the World Breastfeeding Trends Initiative. There are some 40 countries undergoing training towards completing the World Breastfeeding Trends Initiative.

Presently, about 28% of all maternity facilities in the world have implemented the Ten Steps to Successful Breastfeeding. This has contributed to an encouraging increase in breastfeeding rates despite aggressive commercial promotion of infant formula and baby bottles.

The Ten Steps To Successful Breastfeeding are as follows: 1) Have a written breastfeeding policy that is communicated routinely to all healthcare staff; 2) Train all health-care staff in the skills necessary to implement the policy; 3) Inform all pregnant women about the benefits and management of breastfeeding; 4) Help mothers initiate breastfeeding within the first 30 minutes of life; 5) Show mothers how to breastfeed and how to maintain lactation even if separated from their infants; 6) Give newborn infants no food or drink other than human milk unless medically-indicated; 7) Practice rooming- in. Allow mothers and infants to stay together 24 hours a day; 8) Encourage breastfeeding on demand; 9) Give no artificial teats or pacifiers; and 10) Foster establishment of breastfeeding support groups and refer mothers on discharge from hospital or clinic.



FDA approves first oral drug to reduce MS relapses
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226755.htm

FDA significantly restricts access to the diabetes drug Avandia
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226975.htm

Learn How You Can Prevent and Control Rabies. Everyday.
http://www.cdc.gov/Features/Rabies/

U.S FDA New and Generic Drug Approvals September 22, 2010
September 22, 2010

* Alprazolam Tablets, Boca Pharmacal, Inc., Approval
* Asmanex Twisthaler (mometasone furoate) Inhalation Powder, Schering-Plough Corporation, Approval
* Atomoxetine Hydrochloride Capsules, Zydus Pharmaceuticals, Approval
* Atazanavir Sulfate Capsules, Matrix Laboratories Ltd., Tentative Approval
* Casodex (bicalutamide) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision
* Duloxetine Hydrochloride Delayed-Release Capsules, Zydus Pharmaceuticals, Tentative Approval
* Fosinopril Sodium and Hydrochlorothiazide Tablets, Actavis Totowa LLC, Approval
* Gemfibrozil Tablets, Northstar Healthcare Holdings Ltd., Approval
* Nifedipine Extended-Release Tablets, Matrix Laboratories Ltd., Approval
* Nizoral A-D (ketoconazole) Shampoo, McNeil Consumer Healthcare, Approval
* Rifampin Injection, Covenant Pharma, Inc., Approval
* Tacrolimus Capsules, Mylan Pharmaceuticals, Inc., Approval


FDA's MedWatch Safety Alerts: August 2010
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm226967.htm

Risky Sexual Enhancers

Prolatis, Novacare LLC Products, Mr. Magic Male Enhancer, TimeOut Capsules and Revivexxx Extra Strength, marketed as dietary supplements for sexual enhancement, contain undeclared ingredients. Novacare LLC Products are sold under the names of Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis, Xytamax, Maxyte, Libidinal, OMG, OMG45, and Zilex (with Golden Spear)

The undeclared chemicals in these products may lower blood pressure to dangerous levels if taken with nitrate-containing prescription drugs, such as those used to treat diabetes, high cholesterol, and other conditions.

Recommendations

* Stop using these products immediately.
* If you have experienced any bad side effects while using these products, report them to your health professional.

For More Information

* Prolatis: Undeclared Drug Ingredient4
* Novacare LLC Products:Recall -- Undeclared Drug Ingredient5
* Mr. Magic Drug Enhancer: Undeclared Drug Ingredient6
* TimeOut Capsules: Undeclared Drug Ingredient7


Dangerous Weight Control Pills

Solo Slim and Solo Slim Extra Strength products contain an undeclared ingredient to reduce appetite that should be used only in drugs prescribed by a doctor. The ingredient may present a significant health risk for patients with a history of various heart diseases.

Recommendations

* Stop using these products immediately, and return them to the store for a refund.
* If you have experienced any bad side effects while using these products, report them to your health professional.

For More Information

* Solo Slim, Solo Slim Extra Strength: Recall - Undeclared Drug Ingredient8


Poorly Performing Tourniquets

Suspected counterfeit Combat Application Tourniquets (C-A-T®) have a weak tension rod that breaks or bends before the strap can be sufficiently tightened to stop the blood flow.

The resulting excessive blood loss can endanger the victim’s life and ultimately lead to death.

Recommendations

* Use only C-A-T® tourniquets manufactured by Composite Resources and purchased from an authorized distributor.
* If you have C-A-T® tourniquets you suspect may be counterfeit, replace them with the genuine devices.
* If you suspect your tourniquet is counterfeit, contact the FDA’s Office of Criminal Investigations (OCI): Alex Alvarado, special agent, FDA Office of Criminal Investigations – (240) 276-9407.

For More Information

* Combat Application Tourniquets (CAT): Suspected Counterfeit Product9
* FDA's Office of Criminal Investigations10


Infected Blood-Testing Devices

There has been an increase in blood infections (mostly of hepatitis B) transmitted by reusable fingersticks and other skin-puncturing devices such as blood glucose meters, anticoagulation meters, and cholesterol testing devices that are used to draw small blood specimens for testing. When used on more than one patient, these devices may not be safe because it is difficult to clean and disinfect them enough to remove all of the blood.

Recommendation

* Blood-lancing devices should be used only by one patient and should not be shared.
* If that's not feasible, the devices should be thoroughly cleaned and disinfected as described in the labeling.

For More Information

* Fingerstick Devices To Obtain Blood Specimens -- Initial Communication -- Risk of Transmitting Blood Pathogens

Page Last Updated: 09/24/2010


Siemens Recalls Circuit Breakers Due to Fire Hazard
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10354.html

Taking Care of Myself: A Guide for When I Leave the Hospital
http://www.ahrq.gov/qual/goinghomeguide.htm
Taking Care of Myself: A Guide for When I Leave the Hospital is a guide for patients to help them care for themselves when they leave the hospital. The easy-to-read guide can be used by both hospital staff and patients during the discharge process and provides a way for patients to track their medication schedules, upcoming medical appointments, and important phone numbers.

Download the print version and fill-able PDF (PDF File, 775 KB; PDF Help) to your computer and complete all of the information.

This guide is also available in Spanish.
Contents

Using the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital
About the Guide
Using the Guide

Taking Care of Myself: A Guide for When I Leave the Hospital is a guide that providers can use to give patients the information they need to help them care for themselves when they leave the hospital.

How to use the fill-able PDF file:

Using Adobe® Acrobat® (which allows you to view, create, and save PDF files):

1. Open the file and type your information in the spaces provided.
2. Save the file to your computer.
3. Print the file, if desired.

Using Acrobat Reader® (which allows you to view PDF files):

1. Open the file and type your information in the spaces provided.
2. Print the file.
Note: You will not be able to save any changes made to the PDF file.

Hospital staff use:

* Download the fill-able PDF to your computer and complete all of the information in the guide (except patient question sections).
* Talk with patients about the information in the guide.
* Confirm that patients understand instructions by asking patients to describe, in their own words, what they will do when they leave the hospital (e.g., when and how they will take their medicine, when they will go to their doctor's office).
* Give the patient a copy of the completed guide to take home and instruct them to take it to future medical appointments.

Patient use:

* Become familiar with the information covered in the guide before you enter the hospital.
* Make sure that the information about you in the guide is correct (e.g. medication allergies, contact information, primary care provider information).
* Study the guide with your clinicians to make sure you or your family members understand everything that is in it and how to care for yourself when you get home.
* Take the guide to your future medical appointments.

How to Order A Copy of This Guide

To get a free copy of this guide, send an E-mail to the AHRQ Publications Clearinghouse at AHRQPubs@ahrq.hhs.gov or call 1-800-358-9295 and ask for AHRQ Publication No. 10-0059. For other consumer and patient materials, go to the AHRQ Web site at: http://www.ahrq.gov/consumer.


Taking Care of Myself: A Guide for When I Leave the Hospital

To use this guide you should:

* Talk with the hospital staff about each of the items that are listed in the guide.
* Take the completed guide home with you. It will help you to take care of yourself when you go home.
* Share the guide with your family members and others who want to help you. The guide will help them know how to help take care of you.
* Bring the guide to all of your doctor appointments so the doctor knows what you have been doing to care for yourself since you left the hospital.

When you leave the hospital, there are a lot of things you need to do to take care of yourself. You need to see your doctor, take your medicines, exercise, eat healthy foods, and know whom to call with questions or problems. This guide helps you keep track of all the things you need to do.

My name: _______________________________________________

When I'm leaving the hospital _______________________________

If I have questions or problems, I should call:

________________________________________________________

Phone number: __________________________________________

If I have a serious health problem, I should call:

________________________________________________________

Phone number: ___________________________________________

Bring this plan to all your medical appointments.

What is my medical problem?
______________________________________________________________________________

______________________________________________________________________________

What are my medication allergies?
______________________________________________________________________________

______________________________________________________________________________

Where is my pharmacy?
______________________________________________________________________________

______________________________________________________________________________

What exercises are good for me?
______________________________________________________________________________

______________________________________________________________________________

What should I eat?
______________________________________________________________________________

______________________________________________________________________________

What activities or foods should I avoid?
______________________________________________________________________________

______________________________________________________________________________
What medicines do I need to take?

Each day, follow this schedule:
Morning Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much
do I take? How do I take this medicine?








Afternoon Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?








Evening Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?








Bedtime Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?








What other medicines can I take?
Medication name
and amount How much
do I take? How do I take this medicine?
If I need medicine for a headache
If I need medicine to stop smoking
If I need medicine for
______________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________

____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment

Check any of the boxes below and write notes to remember what to discuss with your doctor.

I have questions about:

___ My medicines ________________________________________________

___ My test results ________________________________________________

___ My pain _____________________________________________________

___ Feeling stressed _____________________________________________

Other questions or concerns ________________________________________

___________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________

____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment

Check any of the boxes below and write notes to remember what to discuss with your doctor.

I have questions about:

___ My medicines ________________________________________________

___ My test results ________________________________________________

___ My pain _____________________________________________________

___ Feeling stressed _____________________________________________

___ Other questions or concerns ____________________________________

__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________

____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment

Check any of the boxes below and write notes to remember what to discuss with your doctor.

I have questions about:

___ My medicines ________________________________________________

___ My test results ________________________________________________

___ My pain _____________________________________________________

___ Feeling stressed _____________________________________________

___ Other questions or concerns ____________________________________

__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________

____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment

Check any of the boxes below and write notes to remember what to discuss with your doctor.

I have questions about:

___ My medicines ________________________________________________

___ My test results ________________________________________________

___ My pain _____________________________________________________

___ Feeling stressed _____________________________________________

___ Other questions or concerns ____________________________________

__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________

____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment

Check any of the boxes below and write notes to remember what to discuss with your doctor.

I have questions about:

___ My medicines ________________________________________________

___ My test results ________________________________________________

___ My pain _____________________________________________________

___ Feeling stressed _____________________________________________

___ Other questions or concerns ____________________________________

__________________________________________________________
Notes about my medical problem



About the Guide

Taking Care of Myself: A Guide for When I Leave the Hospital is adapted from the Project RED (Re-Engineered Discharge), which was funded by the Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute and operated by the Boston University Medical Center. Project RED showed that preparing patients to care for themselves when they leave the hospital can improve patient safety and reduce re-hospitalization rates. Giving patients an easy-to-understand discharge plan is 1 of 11 elements in the RED process.

More information about Project RED and tools to support some of the other elements of the RED can be obtained at: https://www.bu.edu/fammed/projectred/ Exit Disclaimer

More detailed tools for implementing RED, and revisions of existing tools to ensure that diverse populations—especially patients with limited English proficiency, are now being developed. The tools will be completed by late 2012 and posted on the AHRQ Web site and the Boston University Medical Center's Project RED Web site.



AHRQ Publication Number 10-0059-C
Current as of April 2010

Internet Citation:

Taking Care of Myself: A Guide for When I Leave the Hospital. AHRQ Publication No. 10-0059-C, April 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/goinghomeguide.htm


AHRQ

____________________________________________________________________________________________________________________________________________________________
Lax security on September 24, 2010, at entrance to SM Building at Ayala Center, Makati. The guards at said entrance didn't inspect my luggage/didn't
subject said luggage to scanning with metal detector. Said luggage was large enough to contain firearms. After entering said building, I bought
from the Chowking store in said building. I have the official receipt issued by said store. The employee at said store didn't have the required
health certificate at the proper position on the clothing she was wearing. No visible express lane for senior citizens in the customer area of
said store. No sign, etc. in the customer area of said store regarding the privileges of senior citizens. I believe said store violated the
implementing rules and regulations of the Expanded Senior Citizens Act of 2003.

Advisory re Digitel Mobile Philippines Inc. Level 1, Space No. 233, Robinsons Place, P. Faura St., Ermita, Manila. On Sept. 23, 2010, said corporation
sold to me a USB Modem, which was stated as compatible with Windows 7 operating system. However, when I tried to use said Modem using Windows 7
operating system to access the Internet, I was unsuccessful. Proof of purchase is said corporation's O.R. No. BRE-1-000540443.

_____________________________________________________________________________________

LAUNCHES ‘D.E.N.G.U.E.’ STRATEGY
http://www.doh.gov.ph/node/2768.html
Sec Ona speaking during launching of dengue strategyPress Release/1 September 2010

The Department of Health (DOH) today assured that many dengue cases, if mild, can be managed at home and not all cases require hospitalization even as the number of cases nationwide from January to August 21 now rose to 62,503.

This figure is 88.8% higher than last year’s 33,102 for the same period. There were 465 deaths recorded this year. Last year, there were 350 deaths.

“Instead of confining patients in a hospital facility, parents and caregivers can practice the D.E.N.G.U.E. strategy. D.E.N.G.U.E. stands for D - daily monitoring of patient’s status, E - encourage intake of oral fluids like oresol, water, juices, etc, N – note any dengue warning signs like persistent vomiting and bleeding, G – give paracetamol for fever and NOT aspirin, because aspirin induces bleeding, U – use mosquito nets and E – early consultation is advised for any warning signs”, Health Secretary Enrique Ona said.

The new D.E.N.G.U.E. strategy has been devised by the DOH to educate the public on home treatment of mild dengue cases. This is to also help decongest hospitals by giving an assurance that not all dengue cases require hospital confinement but can be managed at home using the said strategy.

Ona also reiterated that the most effective way to prevent and fight dengue is still by practicing the DOH’s 4-S strategy consisting of Search and destroy, Self-protective measures, Seek early treatment and Say no to indiscriminate fogging.

“We are urging all local government units to mobilize barangay dengue brigades in their areas,” Ona explained, adding that a once-a-week community-wide clean up drives against dengue will help a lot in reducing cases. Measures include emptying of all exposed containers and vases, old tires, coconut husks, and plants of stagnant waters. Abandoned lots, houses and establishments should also be included in the search-and-destroy operations because these may have possible mosquito breeding sites.

Ona revealed that most of the cases came from Western Visayas (16.1%), CaLaBarzon (10.9%), Central Mindanao (10.5%), Eastern Visayas (9.2%), National Capital Region (8.9%), Southern Mindanao (8.1%) and Northern Mindanao (7.4%).

Ages of cases ranged from 1 month to 95 years old. Majority (52%) of the cases were male. The most affected age group were the 1-10 years while there were more deaths recorded in the less than one year age group and the 1-10 years age group).

Ona disclosed that outbreaks were detected in Roxas City and Iloilo City in Region VI and Zamboanga City in Region IX.

The health chief explained that a hotspot is defined as clustering of cases with increasing number in the past four weeks. Hotspots were observed in the several barangays in the following areas: Lipa City and San Jose in Batangas (Region 4A); Puerto Princesa City in Palawan (Region 4B); Kalibo, Aklan (Region VI); Tagbilaran City, Bohol (Region VII); Pudtol, Apayao (CAR) and ; Kalookan and Valenzuela in NCR.

On the other hand, clustering of cases occur when there are three or more cases in a barangay in the past four weeks. Clustering of cases was noted in many areas in different Regions of the country.

At the National Capital Region, most of the cases were reported from Quezon City.

“The increase in dengue cases can be attributed to the presence of four different strains of the dengue virus circulating in the country today, plus the fact that the country is experiencing the El Niño phenomenon,” Ona elaborated, adding that continuous rains is also responsible for the upsurge in cases.

To more strongly respond to the increasing number of dengue cases, the DOH has ramped up efforts in its public education and information campaign to schools and barangays since July in coordination with its regional health offices and other concerned government agencies such as the Department of Education (DepEd) and the Department of Interior and Local Government (DILG).

Secretary Ona has also reiterated the directive to activate all dengue express lanes in DOH and to network with regional and provincial blood centers where patients can access safe and clean blood for transfusion in severe cases.

“There is still no cure or vaccine for dengue and that is why we must focus on other cost-effective interventions, the most important of which is source reduction --- destroy the dengue-carrying mosquitoes,” Ona emphasized.

The health department is currently looking into other potential strategies to combat dengue such as the use of vaccines against all four dengue strains, the genetic modification of the Aedes mosquitoes which will render them less active in biting victims and even local alternatives such as the use of “Tawa-tawa”, a local herb that is being investigated for its curative properties against dengue.

“We are on the lookout for the emerging science and trends concerning dengue which can help us to more effectively fight the disease in the future,” says Ona. “Meanwhile, we are doing everything we can to arm the public with information and respond to the medical needs of victims given the tools that are currently available to us,” he added.

Ona reminded the public that dengue, although an all-year round disease, is more common during rainy days when there are more potential breeding grounds for the Aedes aegypti mosquitoes. To prevent dengue, Ona advised the public to destroy all possible mosquito breeding sites like old tires, softdrink bottles and tin cans, and use mosquito nets or protective clothing. He also stressed that fogging may be done only in outbreak areas.

ANTI-DENGUE CAMPAIGN IN LRT
http://www.doh.gov.ph/
Health Secretary Enrique Ona explains to a young boy the Department of Health’s 4-S strategy against dengue Health Secretary Enrique Ona explains to a young boy the Department of Health’s 4-S strategy against dengue because the population most affected by the disease are the 1-10 years age group. The DOH’s 4-S campaign includes Search and destroy all mosquito breeding sites, Seek early consultation once dengue is suspected, wear Self-protective clothing to prevent mosquito bites, and Say no to indiscriminate fogging, because there are certain conditions that should be observed during fogging operation. Assisting Secretary Ona is Light Railway Transit Authority Division Chief Mr. Joseph Hagos. From January to August 21 this year, dengue cases nationwide reached 62,503 with 465 deaths.


Advisory vs. Gigahertz store at SM Megamall in Mandaluyong. On September 1, 2010, an employee at said store accepted an order for creation of a recovery disk for
a computer I was thinking of buying. However, even after I paid for said recovery disk and said computer, said store has not provided me with said disk. Proof
of payment is Gigahertz store sales invoice No. 10830 dated September 1, 2010. In addition, there was no visible required express lane for senior citizens in
the customer area of said store and no visible required sign regarding privileges of senior citizens in the customer area of said store. I believe
said store violated the Expanded Senior Citizens Act of 2003.

Toshiba Recalls T Series Notebook Computers Due to Burn Hazard
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10330.html
U.S. Consumer Product
Safety Commission
www.cpsc.gov Health Canada
www.hc-sc.gc.ca


FOR IMMEDIATE RELEASE
September 2, 2010
Release #10-330 Firm's Recall Hotline: (800) 457-7777
CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908
HC Media Contact: (613) 957-2983
Toshiba Recalls T Series Notebook Computers Due to Burn Hazard

WASHINGTON, D.C. - The U.S. Consumer Product Safety Commission and Health Canada, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product.

Name of Product: Satellite T135, Satellite T135D and Satellite ProT130 Notebook Computers

Units: About 41,000 worldwide

Manufacturer: Toshiba America Information Systems Inc., of Irvine, Calif.

Hazard: The notebook computers can overheat at the notebook's plug-in to the AC adapter, posing a burn hazard to consumers.

Incidents/Injuries: Toshiba has received 129 reports of the notebook computers overheating and deforming the plastic casing area around the AC adapter plug, including two reports of minor burn injuries that did not require medical attention and two reports of minor property damage.

Description: This recall involves certain Toshiba Satellite T135, Satellite T135D and Satellite Pro T130 notebook computer models. "Toshiba" is printed on the top of the notebook computer. The model name and number are printed on a label on the bottom of the notebook computers.

Sold at: Electronics stores and other retailers nationwide and online, including at Toshibadirect.com and other websites, from August 2009 through August 2010 for between $600 and $800.

Manufactured in: China

Remedy: Consumers should immediately download the latest version of Toshiba's BIOS computer program to their notebook computer at http://laptops.toshiba.com/about/consumer-notices. This new computer program will detect whether the notebook computer is overheating, and if so, disable the notebook computer's external power and display a message directing the consumer to contact Toshiba for a free repair. Consumers who do not have Internet access should contact Toshiba to arrange for installation of the updated BIOS.

Consumer Contact: For additional information, contact Toshiba at (800) 457-7777 anytime or visit the firm's website at http://laptops.toshiba.com/about/consumer-notices

Note: Health Canada's press release is available at http://cpsr-rspc.hc-sc.gc.ca/PR-RP/recall-retrait-eng.jsp?re_id=1157


*
Warning Letters Posted on August 31, 2010
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/default.htm#recent

Letter Issue Date Company Name Issuing Office Subject Close Out Date
August 25, 2010 Specialty Brands of America Center for Food Safety and Applied Nutrition Federal Food, Drug and Cosmetic Act/Misbranded Not Issued *
August 25, 2010 Sun Pharmaceutical Industries Inc New Jersey District Office CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
August 24, 2010 Storz Medical, AG Center for Devices and Radiological Health CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated Not Issued *
August 23, 2010 Sallamander Concepts CC Pty Ltd Center for Devices and Radiological Health Premarket Approval/Misbranded/Adulterated Not Issued *
August 23, 2010 Stericon Pharma Pvt. Ltd. Center for Drug Evaluation and Research CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
August 16, 2010 R&P Seafood Corp. Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
August 09, 2010 Village Green Foods, Inc. Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
August 09, 2010 Diasol Inc Los Angeles District Office CGMP/QSR/Medical Devices/Adulterated Not Issued *
August 05, 2010 BioVeda Florida District Office Premarket Approval/Misbranded/Adulterated Not Issued *
August 03, 2010 Baxter Healthcare Corp Dba Biolife Plasma Center for Biologics Evaluation and Research Misleading Efficacy Claim Not Issued *
June 21, 2010 Alphatec Spine, Inc. Los Angeles District Office CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated/Misbranded Not Issued *
May 12, 2010 Laboratorios L.O., Oftalmi, C.A. Center for Drug Evaluation and Research CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
-

Contact Us

*

Dockets Management
* 301-827-6860
* Fax: 301-827-6870

Division of Dockets Management

Food and Drug Administration

5630 Fishers Lane

Room 1061, HFA-305

Rockville, MD 20852

-
-
-
Links on this page:

1. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2010/default.htm
2. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2009/default.htm
3. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2008/default.htm
4. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2007/default.htm
5. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2006/default.htm
6. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2005/default.htm
7. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2004/default.htm
8. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2003/default.htm
9. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2002/default.htm
10. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2001/default.htm
11. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2000/default.htm
12. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1999/default.htm
13. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1998/default.htm
14. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1997/default.htm
15. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1996/default.htm
16. http://www.fda.govhttps://service.govdelivery.com/service/subscribe.html?code=USFDA_63
17. http://www.accessdata.fda.gov/scripts/warningletters/wlAdvancedSearch.cfm
18. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterByCompany.cfm
19. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterByOffice.cfm
20. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterBySubject.cfm
21. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchResult.cfm?company=&_1_issueDt=&_2_issueDt=&office=&subject=&hasResponseLetter=Yes&hasCloseoutLetter=Both&recsPerPageDef=500&Search=Search&errMsg=
22. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchResult.cfm?company=&_1_issueDt=&_2_issueDt=&office=&subject=&hasResponseLetter=Both&hasCloseoutLetter=Yes&recsPerPageDef=500&Search=Search&errMsg=
23. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchExcel.cfm
24. http://www.fda.gov/RegulatoryInformation/FOI/WhotoContactAboutFOIA/default.htm
25. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224023.htm
26. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224177.htm
27. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224014.htm
28. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224465.htm
29. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223965.htm
30. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223902.htm
31. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223971.htm
32. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223938.htm
33. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223688.htm
34. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224225.htm
35. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223696.htm
36. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223911.htm

Page Last Updated: 06/24/2010



web sites:

http://www.addictivetips.com/
addictivetips com web site


http://www.nasa.gov/multimedia/imagegallery/
nasa gov multimedia image gallery web site


useful free online services:

let simon decide
http://www.letsimondecide.com/

http://hunch.com/

http://www.measy.com/

CDC Hurricane Health & Safety Tip
...
From:
CDC



Tip of the Week: As you prepare for Hurricane, remember to take rubber boots, rubber gloves and goggles with you when you evacuate. They will protect you from
contaminated flood waters when you return after the storm.